nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0531	0.0569	CcSEcCtD
Atenolol—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0386	0.0414	CcSEcCtD
Atenolol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0263	CcSEcCtD
Atenolol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0238	0.0255	CcSEcCtD
Atenolol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0234	CcSEcCtD
Atenolol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0199	0.0213	CcSEcCtD
Atenolol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0209	CcSEcCtD
Atenolol—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0206	CcSEcCtD
Atenolol—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.019	0.0204	CcSEcCtD
Atenolol—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0202	CcSEcCtD
Atenolol—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0202	CcSEcCtD
Atenolol—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0201	CcSEcCtD
Atenolol—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0201	CcSEcCtD
Atenolol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0198	CcSEcCtD
Atenolol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0191	CcSEcCtD
Atenolol—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0189	CcSEcCtD
Atenolol—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0188	CcSEcCtD
Atenolol—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0181	CcSEcCtD
Atenolol—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0179	CcSEcCtD
Atenolol—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0174	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.016	0.0172	CcSEcCtD
Atenolol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0152	CcSEcCtD
Atenolol—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0145	CcSEcCtD
Atenolol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0144	CcSEcCtD
Atenolol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0141	CcSEcCtD
Atenolol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0139	CcSEcCtD
Atenolol—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0137	CcSEcCtD
Atenolol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0134	CcSEcCtD
Atenolol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0127	CcSEcCtD
Atenolol—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0117	0.177	CbGpPWpGaD
Atenolol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0123	CcSEcCtD
Atenolol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0122	CcSEcCtD
Atenolol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.011	0.0118	CcSEcCtD
Atenolol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0117	CcSEcCtD
Atenolol—Tension—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0113	CcSEcCtD
Atenolol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0112	CcSEcCtD
Atenolol—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0108	CcSEcCtD
Atenolol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00995	0.0107	CcSEcCtD
Atenolol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0104	CcSEcCtD
Atenolol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00964	0.0103	CcSEcCtD
Atenolol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00962	0.0103	CcSEcCtD
Atenolol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00948	0.0102	CcSEcCtD
Atenolol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00943	0.0101	CcSEcCtD
Atenolol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00936	0.01	CcSEcCtD
Atenolol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00913	0.00978	CcSEcCtD
Atenolol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0091	0.00975	CcSEcCtD
Atenolol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00902	0.00966	CcSEcCtD
Atenolol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00893	0.00956	CcSEcCtD
Atenolol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00883	0.00945	CcSEcCtD
Atenolol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00875	0.00938	CcSEcCtD
Atenolol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00861	0.00922	CcSEcCtD
Atenolol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00857	0.00918	CcSEcCtD
Atenolol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00854	0.00915	CcSEcCtD
Atenolol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00846	0.00906	CcSEcCtD
Atenolol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00834	0.00894	CcSEcCtD
Atenolol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00818	0.00876	CcSEcCtD
Atenolol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00792	0.00848	CcSEcCtD
Atenolol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00842	CcSEcCtD
Atenolol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0078	0.00836	CcSEcCtD
Atenolol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00833	CcSEcCtD
Atenolol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00771	0.00825	CcSEcCtD
Atenolol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00761	0.00815	CcSEcCtD
Atenolol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00755	0.00808	CcSEcCtD
Atenolol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00802	CcSEcCtD
Atenolol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00802	CcSEcCtD
Atenolol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00721	0.00773	CcSEcCtD
Atenolol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00692	0.00741	CcSEcCtD
Atenolol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00673	CcSEcCtD
Atenolol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00663	CcSEcCtD
Atenolol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00641	CcSEcCtD
Atenolol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0062	CcSEcCtD
Atenolol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00591	CcSEcCtD
Atenolol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00591	CcSEcCtD
Atenolol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00587	CcSEcCtD
Atenolol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00557	CcSEcCtD
Atenolol—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00487	0.0734	CbGpPWpGaD
Atenolol—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00477	0.0718	CbGpPWpGaD
Atenolol—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0041	0.0617	CbGpPWpGaD
Atenolol—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00401	0.0604	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00299	0.045	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00292	0.044	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00212	0.0319	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00155	0.0233	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00151	0.0228	CbGpPWpGaD
Atenolol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00146	0.022	CbGpPWpGaD
Atenolol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00143	0.0215	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000941	0.0142	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00092	0.0139	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000806	0.0121	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000788	0.0119	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00071	0.0107	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000695	0.0105	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000667	0.0101	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000667	0.0101	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.000645	0.00972	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.000631	0.0095	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000614	0.00925	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.0006	0.00904	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000595	0.00896	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.000561	0.00846	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.000549	0.00827	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000544	0.00819	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000544	0.00819	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00048	0.00723	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000469	0.00707	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000448	0.00675	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.000438	0.0066	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.000436	0.00656	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.000426	0.00642	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000412	0.00621	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000412	0.00621	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000383	0.00577	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000383	0.00577	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.000381	0.00574	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.000373	0.00561	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000347	0.00522	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000342	0.00515	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000342	0.00515	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000339	0.00511	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.000317	0.00478	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000315	0.00474	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00031	0.00467	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000308	0.00464	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.000288	0.00434	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.000282	0.00424	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000273	0.00411	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000257	0.00388	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.000257	0.00388	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.000252	0.00379	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000252	0.00379	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000237	0.00357	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000211	0.00318	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000186	0.0028	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000182	0.00274	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000179	0.0027	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APRT—nephrolithiasis	0.000179	0.0027	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.00017	0.00256	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000166	0.00251	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000128	0.00193	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000116	0.00174	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	8.54e-05	0.00129	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	8.36e-05	0.00126	CbGpPWpGaD
